0000950123-24-012261 Sample Contracts
COMMERCIALIZATION AGREEMENTCommercialization Agreement • December 16th, 2024 • Beta Bionics, Inc • Surgical & medical instruments & apparatus • Delaware
This Commercialization Agreement (this “Agreement”) is made and entered into as of July 25, 2023 (the “Effective Date”) by and between Beta Bionics, Inc., a Massachusetts public benefit corporation having a principal place of business at 11 Hughes, Irvine, CA 92618 (“Beta Bionics”) and DexCom, Inc., a Delaware corporation having a principal place of business at 6340 Sequence Drive, San Diego, CA 92121 (“DexCom”). In this Agreement, Beta Bionics and DexCom are each a “Party” and, collectively, the “Parties”. Capitalized terms used and not defined herein shall have the meanings ascribed to them in the Development Agreement.